Kabi Introduces Idacio Into Crowded German Adalimumab Market

 
• By Aidan Fry
  
Germany
Kabi's Idacio will have to compete for share as the fifth adalimumab biosimilar to enter the German market • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products